keyword
https://read.qxmd.com/read/38347617/discovery-of-dual-kinase-inhibitors-targeting-vegfr2-and-fak-structure-based-pharmacophore-modeling-virtual-screening-and-molecular-docking-studies
#21
JOURNAL ARTICLE
Marwa A Fouad, Alaa A Osman, Noha M Abdelhamid, Mai W Rashad, Ashrakat Y Nabawy, Ahmed M El Kerdawy
VEGFR2 and FAK signaling pathways are interconnected and have synergistic effects on tumor angiogenesis, growth, and metastasis. Thus, instead of the conventional targeting of each of these proteins individually with a specific inhibitor, the present work aimed to discover novel dual inhibitors targeting both VEGFR2 and FAK exploiting their association. To this end, receptor-based pharmacophore modeling technique was opted to generate 3D pharmacophore models for VEGFR2 and FAK type II kinase inhibitors...
February 12, 2024: BMC chemistry
https://read.qxmd.com/read/38344494/heparin-induced-thrombocytopenia-a-case-report-four-years-after-the-initiation-of-maintenance-hemodialysis
#22
Junichiro Nishiyama, Keishi Higashi
Heparin-induced thrombocytopenia type II (HIT) is a rare and serious complication of heparin exposure and is always a potential risk in hemodialysis patients who routinely receive heparin. It is particularly likely to occur during the induction phase of dialysis. However, it is known to be less prevalent in long-term maintenance dialysis. In the present study, we experienced a maintenance dialysis patient who developed HIT four years after starting dialysis. After careful diagnosis with antibodies assay and clinical scores, the patient was treated with immediate heparin interruption, argatroban administration followed by nafamostat, and simple plasma exchange, which resulted in remission...
January 2024: Curēus
https://read.qxmd.com/read/38305404/design-virtual-screening-molecular-docking-adme-and-cytotoxicity-studies-of-1-3-5-triazine-containing-heterocyclic-scaffolds-as-selective-braf-monomeric-homo-and-heterodimeric-inhibitors
#23
JOURNAL ARTICLE
Ankit Kumar Singh, P Sreelakshmi, Prateek Pathak, Adarsh Kumar, Harshwardhan Singh, Jagat Pal Yadav, Amita Verma, Maria Grishina, Pradeep Kumar
BACKGROUND: v-RAF murine sarcoma viral homolog B1 (BRAF) is one of the most frequently mutated kinases in human cancers. BRAF exhibits three classes of mutations: Class I monomeric mutants (BRAFV600), class II BRAF homodimer mutants (non-V600), and class III BRAF heterodimers (non-V600). METHOD: In this manuscript, the protein-ligand interaction site of all three mutants: BRAF monomer, BRAF homodimer BRAF2:14-3-32, and BRAF heterodimer BRAF:14-3-32:MEK (Mitogen extracellular Kinase) has been discussed...
January 17, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38285222/digitally-enhanced-hands-on-surgical-training-dehst-enhances-the-performance-during-freehand-nail-distal-interlocking
#24
JOURNAL ARTICLE
Torsten Pastor, Emanuele Cattaneo, Tatjana Pastor, Boyko Gueorguiev, Frank J P Beeres, Björn-Christian Link, Markus Windolf, Jan Buschbaum
PURPOSE: Freehand distal interlocking of intramedullary nails remains a challenging task. Recently, a new training device for digitally enhanced hands-on surgical training (DEHST) was introduced, potentially improving surgical skills needed for distal interlocking. AIM: To evaluate whether training with DEHST enhances the performance of novices (first-year residents without surgical experience in freehand distal nail interlocking). METHODS: Twenty novices were randomly assigned to two groups and performed distal interlocking of a tibia nail in mock operation under operation-room-like conditions...
January 29, 2024: Archives of Orthopaedic and Trauma Surgery
https://read.qxmd.com/read/38273156/the-identification-of-c-abl-inhibitors-as-potential-agents-for-parkinson-s-disease-a-preliminary-in-silico-approach
#25
JOURNAL ARTICLE
Emdormi Rymbai, Dhritiman Roy, Srikanth Jupudi, Venkatesan Srinivasadesikan
Parkinson's disease (PD) is the most common movement disorder worldwide. PD is primarily associated with the mutation, overexpression, and phosphorylation of α-synuclein. At the molecular level, the upstream protein c-Abl, a tyrosine kinase, has been shown to regulate α-synuclein activation and expression patterns. This study aimed to identify potential c-Abl inhibitors through in silico approaches. Molecular docking was performed using PyRx software, followed by Prime MM-GBSA studies. BBB permeability and toxicity were predicted using CBligand and ProTox-II, respectively...
January 25, 2024: Molecular Diversity
https://read.qxmd.com/read/38237077/a-phase-i-ii-trial-of-da-epoch-r-plus-ixazomib-for-myc-aberrant-lymphoid-malignancies-the-daciphor-regimen
#26
JOURNAL ARTICLE
Reem Karmali, Carlos Galvez, Mehdi Hamadani, Leo I Gordon, Jane N Winter, Shuo Ma, Valerie Nelson, Timothy S Fenske, Nirav N Shah, Deepa Jagadeesh, Andreas K Klein, Irene Helenowski, Ruohui Chen, Xinlei Mi, Adam Petrich, Andrew M Evens, Barbara Pro
MYC-aberrant non-Hodgkin lymphoma (NHL) is associated with poor outcomes with conventional chemotherapy. Ixazomib is an orally bioavailable proteasome inhibitor that targets drivers of MYC expression and has demonstrated preclinical activity in aggressive MYC-aberrant NHL. We conducted a phase I/II study evaluating the safety and efficacy of induction DA-EPOCH-R and ixazomib followed by ixazomib maintenance in aggressive MYC-aberrant NHL. For induction, patients received 6 cycles of DA-EPOCH-R with ixazomib administered twice per 21-day cycle; ixazomib maintenance was administered weekly in responders for up to 1 year...
January 18, 2024: Blood Advances
https://read.qxmd.com/read/38218127/phenoxytacrine-derivatives-low-toxicity-neuroprotectants-exerting-affinity-to-ifenprodil-binding-site-and-cholinesterase-inhibition
#27
JOURNAL ARTICLE
Anna Misiachna, Barbora Svobodova, Jakub Netolicky, Marketa Chvojkova, Lenka Kleteckova, Lukas Prchal, Martin Novak, Martina Hrabinova, Tomas Kucera, Lubica Muckova, Zuzana Moravcova, Jana Zdarova Karasova, Jaroslav Pejchal, Filip Blazek, David Malinak, Kristina Hakenova, Barbora Hrcka Krausova, Marharyta Kolcheva, Marek Ladislav, Jan Korabecny, Jens Pahnke, Karel Vales, Martin Horak, Ondrej Soukup
Tacrine (THA), a long withdrawn drug, is still a popular scaffold used in medicinal chemistry, mainly for its good reactivity and multi-targeted effect. However, THA-associated hepatotoxicity is still an issue and must be considered in drug discovery based on the THA scaffold. Following our previously identified hit compound 7-phenoxytacrine (7-PhO-THA), we systematically explored the chemical space with 30 novel derivatives, with a focus on low hepatotoxicity, anticholinesterase action, and antagonism at the GluN1/GluN2B subtype of the NMDA receptor...
January 7, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38206166/direct-heterocycle-c-h-alkenylation-via-dual-catalysis-using-a-palladacycle-precatalyst-multifactor-optimization-and-scope-exploration-enabled-by-high-throughput-experimentation
#28
JOURNAL ARTICLE
Nahiane Pipaón Fernández, Odhran Cruise, Sarah E F Easton, Justin M Kaplan, John L Woodard, Damian P Hruszkewycz, David C Leitch
One of the major challenges in developing catalytic methods for C-C bond formation is the identification of generally applicable reaction conditions, particularly if multiple substrate structural classes are involved. Pd-catalyzed direct arylation reactions are powerful transformations that enable direct functionalization of C-H bonds; however, the corresponding direct alkenylation reactions, using vinyl (pseudo) halide electrophiles, are less well developed. Inspired by process development efforts toward GSK3368715 , an investigational active pharmaceutical ingredient, we report that a Pd(II) palladacycle derived from tri- tert -butylphosphine and Pd(OAc)2 is an effective single-component precatalyst for a variety of direct alkenylation reactions...
January 11, 2024: Journal of Organic Chemistry
https://read.qxmd.com/read/38199412/maternal-deprivation-causes-camkii-downregulation-and-modulates-glutamate-norepinephrine-and-serotonin-in-limbic-brain-areas-in-a-rat-model-of-single-prolonged-stress
#29
JOURNAL ARTICLE
Đorđe Đorović, Vesna Lazarevic, Jovana Aranđelović, Vladimir Stevanović, Wojciech Paslawski, Xiaoqun Zhang, Milica Velimirović, Nataša Petronijević, Laslo Puškaš, Miroslav M Savić, Per Svenningsson
BACKGROUND: Early life stress is a major risk factor for later development of psychiatric disorders, including post-traumatic stress disorder (PTSD). An intricate relationship exists between various neurotransmitters (such as glutamate, norepinephrine or serotonin), calcium/calmodulin-dependent protein kinase II (CaMKII), as an important regulator of glutamatergic synaptic function, and PTSD. Here, we developed a double-hit model to investigate the interaction of maternal deprivation (MD) as an early life stress model and single prolonged stress (SPS) as a PTSD model at the behavioral and molecular levels...
January 8, 2024: Journal of Affective Disorders
https://read.qxmd.com/read/38184819/combination-drug-screen-identifies-synergistic-drug-interaction-of-bcl-xl-and-class-i-histone-deacetylase-inhibitors-in-myc-amplified-medulloblastoma-cells
#30
JOURNAL ARTICLE
Simon Zeuner, Johanna Vollmer, Romain Sigaud, Sina Oppermann, Heike Peterziel, Dina ElHarouni, Ina Oehme, Olaf Witt, Till Milde, Jonas Ecker
PURPOSE: Patients with MYC-amplified Group 3 medulloblastoma (MB) (subtype II) show poor progression-free survival rates. Class I histone deacetylase inhibitors (HDACi) are highly effective for the treatment of MYC-amplified MB in vitro and in vivo. Drug combination regimens including class I HDACi may represent an urgently needed novel treatment approach for this high risk disease. METHODS: A medium-throughput in vitro combination drug screen was performed in three MYC-amplified and one non-MYC-amplified MB cell line testing 75 clinically relevant drugs alone and in combination with entinostat...
January 7, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38177113/a-myc-rearrangement-is-a-negative-prognostic-factor-in-stage-ii-but-not-in-stage-i-diffuse-large-b-cell-lymphoma
#31
JOURNAL ARTICLE
A V de Jonge, J A A Bult, D F E Karssing, M Nijland, M E D Chamuleau, M Brink
MYC oncogene rearrangements (MYC-R) negatively affect survival in patients with Ann Arbor stage III-IV diffuse large B-cell lymphoma (DLBCL), but their impact in limited stage (LS) I-II is unclear. Therefore, we assessed the impact of MYC-R on progression-free survival (PFS) and overall survival (OS) in LS DLBCL patients at the population level. We identified 1,434 LS DLBCL patients with known MYC-R status diagnosed between 2014 and 2020, who received R-CHOP(-like) regimens using the Netherlands Cancer Registry, with survival follow-up until February 2022...
January 4, 2024: Blood Cancer Journal
https://read.qxmd.com/read/38170777/transcriptional-determinants-of-lipid-mobilization-in-human-adipocytes
#32
JOURNAL ARTICLE
Alison C Ludzki, Mattias Hansen, Danae Zareifi, Jutta Jalkanen, Zhiqiang Huang, Muhmmad Omar-Hmeadi, Gianluca Renzi, Felix Klingelhuber, Sebastian Boland, Yohannes A Ambaw, Na Wang, Anastasios Damdimopoulos, Jianping Liu, Tomas Jernberg, Paul Petrus, Peter Arner, Natalie Krahmer, Rongrong Fan, Eckardt Treuter, Hui Gao, Mikael Rydén, Niklas Mejhert
Defects in adipocyte lipolysis drive multiple aspects of cardiometabolic disease, but the transcriptional framework controlling this process has not been established. To address this, we performed a targeted perturbation screen in primary human adipocytes. Our analyses identified 37 transcriptional regulators of lipid mobilization, which we classified as (i) transcription factors, (ii) histone chaperones, and (iii) mRNA processing proteins. On the basis of its strong relationship with multiple readouts of lipolysis in patient samples, we performed mechanistic studies on one hit, ZNF189 , which encodes the zinc finger protein 189...
January 5, 2024: Science Advances
https://read.qxmd.com/read/38167962/spatio-temporal-epidemiology-and-associated-indicators-of-covid-19-wave-i-and-ii-in-india
#33
JOURNAL ARTICLE
Karuppusamy Balasubramani, Venkatesh Ravichandran, Kumar Arun Prasad, Mu Ramkumar, Sulochana Shekhar, Meenu Mariya James, Naveen Kumar Kodali, Sujit Kumar Behera, Natarajan Gopalan, Rakesh Kumar Sharma, Devojit Kumar Sarma, M Santosh, Aditya Prasad Dash, Praveen Balabaskaran Nina
The spatio-temporal distribution of COVID-19 across India's states and union territories is not uniform, and the reasons for the heterogeneous spread are unclear. Identifying the space-time trends and underlying indicators influencing COVID-19 epidemiology at micro-administrative units (districts) will help guide public health strategies. The district-wise daily COVID-19 data of cases and deaths from February 2020 to August 2021 (COVID-19 waves-I and II) for the entire country were downloaded and curated from public databases...
January 2, 2024: Scientific Reports
https://read.qxmd.com/read/38155300/in-silico-prediction-and-in-vitro-assessment-of-novel-heterocyclics-with-antimalarial-activity
#34
JOURNAL ARTICLE
Martha Ilce Orozco, Pedro Moreno, Miguel Guevara, Rodrigo Abonia, Jairo Quiroga, Braulio Insuasty, Mauricio Barreto, Maria Elena Burbano, Maria Del Pilar Crespo-Ortiz
The development of new antimalarials is paramount to keep the goals on reduction of malaria cases in endemic regions. The search for quality hits has been challenging as many inhibitory molecules may not progress to the next development stage. The aim of this work was to screen an in-house library of heterocyclic compounds (HCUV) for antimalarial activity combining computational predictions and phenotypic techniques to find quality hits. The physicochemical determinants, pharmacokinetic properties (ADME), and drug-likeness of HCUV were evaluated in silico, and compounds were selected for structure-based virtual screening and in vitro analysis...
December 29, 2023: Parasitology Research
https://read.qxmd.com/read/38105286/2023-updated-mascc-esmo-consensus-recommendations-prevention-of-nausea-and-vomiting-following-multiple-day-chemotherapy-high-dose-chemotherapy-and-breakthrough-nausea-and-vomiting
#35
JOURNAL ARTICLE
Bernardo Leon Rapoport, Jørn Herrstedt, Rebecca Clark Snow, Venkatraman Radhakrishnan, Mitsue Saito, Rudolph M Navari, Teresa Smit
PURPOSE: This review is an update of the MASCC/ESMO 2015 recommendations for the prophylaxis of acute and delayed nausea and vomiting induced by multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting. METHODS: A systematic literature search was conducted using PubMed from June 1, 2015, through February 1, 2023. RESULTS: We identified 56 references (16 were duplications or invalid), leaving 40 manuscripts for this search...
December 18, 2023: Supportive Care in Cancer
https://read.qxmd.com/read/38100546/high-throughput-virtual-screening-pharmacophore-modelling-and-antagonist-effects-of-small-molecule-inhibitors-against-cytotoxin-induced-cytotoxicity
#36
JOURNAL ARTICLE
En Qi Lim, Nafees Ahemad, Michelle Khai Khun Yap
Cobra venom cytotoxins (CTX) cause dermonecrosis in envenomed patients who suffered from limb amputations due to the limitation of serotherapy-based antivenoms. This study aimed to identify small molecule inhibitors against CTX. A structure-based high-throughput virtual screening (HTVS) was conducted based on a conserved CTX, using the Natural Product Activity and Species Source (NPASS) screening library. The hits were valerenic acid, 1-oxo-2H-isoquinoline-4-carboxylic acid, acenaphthene, and 5-bromopyrrole-2-carboxamide, which interacted with contemporary antivenom binding site A and functional loops I-III of CTX, respectively, in molecular docking studies...
December 15, 2023: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38100359/ascorbic-acid-reprograms-epigenome-and-epitranscriptome-by-reducing-fe-iii-in-the-catalytic-cycle-of-dioxygenases
#37
JOURNAL ARTICLE
Weizhi He, Xiaotong Yin, Chu Xu, Xiangyue Liu, Yue Huang, Caiguang Yang, Yanhui Xu, Lulu Hu
Ascorbic acid (ASC) has been reported to stimulate DNA iterative oxidase ten-eleven translocation (TET) enzymes, Jumonji C-domain-containing histone demethylases, and potentially RNA m6 A demethylases FTO and ALKBH5 as a cofactor. Although ascorbic acid has been widely investigated in reprogramming DNA and histone methylation status in vitro , in cultured cells and mouse models, its specific role in the catalytic cycle of dioxygenases remains enigmatic. Here, we systematically investigated the stimulation of ASC toward TET2, ALKBH3, histone demethylases, and FTO...
December 15, 2023: ACS Chemical Biology
https://read.qxmd.com/read/38093937/retracted-network-pharmacology-reveals-polyphyllin-ii-as-one-hit-of-nano-chinese-medicine-monomers-against-nasopharyngeal-carcinoma
#38
Bioinorganic Chemistry And Applications
[This retracts the article DOI: 10.1155/2021/9959634.].
2023: Bioinorganic Chemistry and Applications
https://read.qxmd.com/read/38075755/crystallographic-fragment-screening-on-the-shigella-type-iii-secretion-system-chaperone-ipgc
#39
JOURNAL ARTICLE
Marina Gárdonyi, Christian Hasewinkel, Johanna Wallbaum, Jan Wollenhaupt, Manfred S Weiss, Gerhard Klebe, Klaus Reuter, Andreas Heine
The Shigella pathogenicity factor IpgC belongs to the class II of type III secretion system chaperones, whose members are characterized by a tetratricopeptide repeat (TPR) domain consisting of three and a half TPR motifs. Since IpgC is essential for Shigella virulence, we determined a high-resolution crystal structure of this chaperone to facilitate its use as a target for the structure-based design of anti-shigellosis compounds. The crystal structure revealed two possible homodimer assemblies, which strongly differ from the homodimer architectures so far known for IpgC and orthologues thereof...
December 5, 2023: ACS Omega
https://read.qxmd.com/read/38068959/a-new-drug-discovery-platform-application-to-dna-polymerase-eta-and-apurinic-apyrimidinic-endonuclease-1
#40
JOURNAL ARTICLE
Debanu Das, Matthew A J Duncton, Taxiarchis M Georgiadis, Patricia Pellicena, Jennifer Clark, Robert W Sobol, Millie M Georgiadis, John King-Underwood, David V Jobes, Caleb Chang, Yang Gao, Ashley M Deacon, David M Wilson
The ability to quickly discover reliable hits from screening and rapidly convert them into lead compounds, which can be verified in functional assays, is central to drug discovery. The expedited validation of novel targets and the identification of modulators to advance to preclinical studies can significantly increase drug development success. Our SaXPyTM ("SAR by X-ray Poses Quickly") platform, which is applicable to any X-ray crystallography-enabled drug target, couples the established methods of protein X-ray crystallography and fragment-based drug discovery (FBDD) with advanced computational and medicinal chemistry to deliver small molecule modulators or targeted protein degradation ligands in a short timeframe...
November 23, 2023: International Journal of Molecular Sciences
keyword
keyword
41194
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.